IL-21, not IL-17A, exacerbates murine primary biliary cholangitis
Clinical and Experimental Immunology · 07.02.2024 · 215 (2) · 137-147
DOI: 10.1093/cei/uxad107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 14.09.2023. Verfasst von Chun-Wen Chan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary, Cholangitis, Autoimmune Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Taiwan University, National Taiwan University College of Medicine, National Taiwan University Hospital.
Abstract (Originalsprache)
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease caused by intrahepatic bile duct injuries, resulting in fibrosis, cirrhosis, and eventually liver failure. T helper (Th) 17 cells are proposed to involve in the pathogenesis of PBC. However, how and which Th17 cell-derived cytokines affect PBC remains unclear. In this study, we investigated the effects of Th17 effector cytokines, including interleukin (IL)-17A, IL-17F, and IL-21 in PBC using a xenobiotic-induced mouse model of autoimmune cholangitis (inducible chemical xenobiotic models of PBC) treated with cytokine-expressing adeno-associated virus. Our results showed that administration of IL-17A, the well-known main cytokine produced by Th17 cells, did not augment liver inflammation or fibrosis. In contrast, we noted IL-17A-treated mice had lower hepatic Th1 cell numbers and higher hepatic CD11b+Ly6G+ polymorphonuclear myeloid-derived suppressor cell numbers. IL-17F did not alter liver inflammation or fibrosis. However, the administration of IL-21 exacerbated liver inflammatory responses and portal cell infiltration. IL-21 markedly increased the numbers of activated CD8+ T cells and liver tissue-resident memory CD8+ T cells. Moreover, IL-21 aggravates liver fibrosis in mice with autoimmune cholangitis. These results emphasized that not IL-17A but IL-21 in Th17 cell-derived cytokines affected the pathogenesis of PBC. IL-21 enhanced liver inflammation and progression to fibrosis by enhancing the numbers and effector activities of CD8+ T cells. Delineation of the effects of different Th17 effector cytokines in PBC offers clues for developing new therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
ORCID-Profile: Ya-Hui Chuang
Förderung
- National Taiwan University
- National Taiwan University College of Medicine
- National Taiwan University Hospital
- Ministry of Science and Technology, Taiwan
- National Health Research Institutes
Zitieren
APA
Chan, C. W., Chen, H. W., Wang, Y. W., Lin, C. I., & Chuang, Y. H. (2024). IL-21, not IL-17A, exacerbates murine primary biliary cholangitis. Clinical and Experimental Immunology, 215(2), 137-147. https://doi.org/10.1093/cei/uxad107
Vancouver
Chan CW, Chen HW, Wang YW, Lin CI, Chuang YH. IL-21, not IL-17A, exacerbates murine primary biliary cholangitis. Clinical and Experimental Immunology. 2024;215(2):137-147. doi:10.1093/cei/uxad107
BibTeX
@article{Chan2024,
author = {Chan, Chun-Wen and Chen, Hung-Wen and Wang, Yu-Wen and Lin, Chia-I and Chuang, Ya-Hui},
title = {IL-21, not IL-17A, exacerbates murine primary biliary cholangitis},
journal = {Clinical and Experimental Immunology},
year = {2024},
volume = {215},
number = {2},
pages = {137--147},
doi = {10.1093/cei/uxad107}
}
EUVIMED